A three-dimensional model of the Fas/APO-1 molecule: cross-reactivity of anti-Fas antibodies explained by structural mimicry of antigenic sites
- PMID: 9533440
- DOI: 10.1093/intimm/10.2.131
A three-dimensional model of the Fas/APO-1 molecule: cross-reactivity of anti-Fas antibodies explained by structural mimicry of antigenic sites
Abstract
Fas/APO-1 is a member of the tumor necrosis factor (TNF)/nerve growth factor receptor family. This cell surface protein, when associated with the Fas/APO-1 ligand or specific mAb, elicits an apoptotic response in susceptible cells via an oligomerization of its intracellular domains, termed the'death domains'. We have previously mapped the epitopes of a panel of Fas/APO-1-reactive mAb to a series of linear portions of the Fas/APO-1 molecule. In order to gain a greater understanding of the mode of interaction of these antibodies with the Fas/APO-1 antigen, we constructed a homology-based model of the extracellular portion of the molecule, based on the crystallographic coordinates of the TNF type I receptor. The model clearly demonstrates that the antibodies do not identically mimic the endogenous ligand to achieve their effect, but probably act in an analogous manner by recruiting Fas/APO-1 molecules into clusters which may lead to oligomerization of 'death domains'. Moreover, the apparent cross-reactivity observed for the monoclonal anti-Fas antibodies between different linear regions of the Fas/APO-1 molecule was found to be due, most likely, to the structural mimicry of these epitopes. Reduction of the Fas/APO-1-derived cross-reactive peptides by dithiothreitol completely abrogated their antigenic reactivity with the anti-Fas mAb CH-11, thus indicating that the establishment of intrapeptide disulfide bonds is critical for antigenic reactivity.
Similar articles
-
Mapping of the linear site on the Fas/APO-1 molecule targeted by the prototypic anti-Fas mAb.Int Immunol. 1995 Dec;7(12):1967-75. doi: 10.1093/intimm/7.12.1967. Int Immunol. 1995. PMID: 8746566
-
Humanization and epitope mapping of neutralizing anti-human Fas ligand monoclonal antibodies: structural insights into Fas/Fas ligand interaction.J Immunol. 2001 Sep 15;167(6):3266-75. doi: 10.4049/jimmunol.167.6.3266. J Immunol. 2001. PMID: 11544314
-
Anti-Fas IgG1 antibodies recognizing the same epitope of Fas/APO-1 mediate different biological effects in vitro.Int Immunol. 1997 Feb;9(2):201-9. doi: 10.1093/intimm/9.2.201. Int Immunol. 1997. PMID: 9040002
-
A family of ligands for the TNF receptor superfamily.Stem Cells. 1994 Sep;12(5):440-55. doi: 10.1002/stem.5530120501. Stem Cells. 1994. PMID: 7528588 Review.
-
Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction.ScientificWorldJournal. 2002 Feb 12;2:421-3. doi: 10.1100/tsw.2002.122. ScientificWorldJournal. 2002. PMID: 12806026 Free PMC article. Review.
Cited by
-
Stimulation of Fas agonistic antibody-mediated apoptosis by heparin-like agents suppresses Hsp27 but not Bcl-2 protective activity.Cell Stress Chaperones. 2004 Summer;9(2):150-66. doi: 10.1379/csc-16r.1. Cell Stress Chaperones. 2004. PMID: 15497502 Free PMC article.
-
The peptide derived from the Ig-like domain of human herpesvirus 8 K1 protein induces death in hematological cancer cells.J Exp Clin Cancer Res. 2012 Aug 28;31(1):69. doi: 10.1186/1756-9966-31-69. J Exp Clin Cancer Res. 2012. PMID: 22929310 Free PMC article.
-
Characterizing the regulatory Fas (CD95) epitope critical for agonist antibody targeting and CAR-T bystander function in ovarian cancer.Cell Death Differ. 2023 Nov;30(11):2408-2431. doi: 10.1038/s41418-023-01229-7. Epub 2023 Oct 14. Cell Death Differ. 2023. PMID: 37838774 Free PMC article.
-
Mechanism of Fas signaling regulation by human herpesvirus 8 K1 oncoprotein.J Natl Cancer Inst. 2009 Mar 18;101(6):399-411. doi: 10.1093/jnci/djn516. Epub 2009 Mar 10. J Natl Cancer Inst. 2009. PMID: 19276446 Free PMC article.
-
The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations.J Clin Invest. 1999 Feb;103(3):355-63. doi: 10.1172/JCI5121. J Clin Invest. 1999. PMID: 9927496 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous